Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CEFEPIME Cause Electrocardiogram qt prolonged? 12 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Electrocardiogram qt prolonged have been filed in association with CEFEPIME (Cefepime). This represents 0.2% of all adverse event reports for CEFEPIME.

12
Reports of Electrocardiogram qt prolonged with CEFEPIME
0.2%
of all CEFEPIME reports
3
Deaths
4
Hospitalizations

How Dangerous Is Electrocardiogram qt prolonged From CEFEPIME?

Of the 12 reports, 3 (25.0%) resulted in death, 4 (33.3%) required hospitalization, and 2 (16.7%) were considered life-threatening.

Is Electrocardiogram qt prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CEFEPIME. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does CEFEPIME Cause?

Drug ineffective (864) Acute kidney injury (706) Off label use (383) Encephalopathy (376) Drug reaction with eosinophilia and systemic symptoms (288) Condition aggravated (242) Confusional state (207) Rash (194) Pyrexia (185) Thrombocytopenia (181)

What Other Drugs Cause Electrocardiogram qt prolonged?

QUETIAPINE (1,869) OLANZAPINE (1,325) RIBOCICLIB (1,020) AMIODARONE (1,000) HYDROXYCHLOROQUINE (992) CLOZAPINE (958) CITALOPRAM HYDROBROMIDE (917) ESCITALOPRAM OXALATE (899) ONDANSETRON (881) BUPROPION (853)

Which CEFEPIME Alternatives Have Lower Electrocardiogram qt prolonged Risk?

CEFEPIME vs CEFEPIME\CEFEPIME CEFEPIME vs CEFIDEROCOL CEFEPIME vs CEFIXIME CEFEPIME vs CEFMETAZOLE CEFEPIME vs CEFOPERAZONE

Related Pages

CEFEPIME Full Profile All Electrocardiogram qt prolonged Reports All Drugs Causing Electrocardiogram qt prolonged CEFEPIME Demographics